Cargando…
Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
Glucose and lipid profile together with blood pressure should always be considered for low sera‐IGF‐1 patients. Even when adulthood is reached, IGF‐1 therapy in these patients should be pursued as metabolic and protective cellular effects could be triggered. Real incidence of growth hormone insensit...
Autores principales: | Castilla‐Cortazar, Inma, Femat‐Roldán, Giovana, Rodríguez‐Rivera, Joel, Aguirre, Gabriel A., García‐Magariño, Mariano, Martín‐Estal, Irene, Espinosa, Luis, Díaz‐Olachea, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676289/ https://www.ncbi.nlm.nih.gov/pubmed/29152285 http://dx.doi.org/10.1002/ccr3.1193 |
Ejemplares similares
-
Is insulin-like growth factor-1 involved in Parkinson’s disease development?
por: Castilla-Cortázar, Inma, et al.
Publicado: (2020) -
Primary growth hormone insensitivity and psychomotor delay
por: Castilla‐Cortazar, Inma, et al.
Publicado: (2018) -
A 42-Year-Old Woman with Untreated Growth Hormone Insensitivity, Diabetic Retinopathy, and Gene Sequencing Identifies a Variant of Laron Syndrome
por: Castilla-Cortazar, Inma, et al.
Publicado: (2019) -
Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
por: Femat-Roldán, Giovana, et al.
Publicado: (2020) -
Growth hormone insensitivity: Mexican case report
por: Castilla-Cortazar, I, et al.
Publicado: (2017)